Media, page-170

This is a good talk. He did mentioned this again that data from the 1st line NSCLC and HNSC will be coming out in 3 months (from the talked day 28th Mar). This round of release might or might not catch the ASCO 2022 in June. Even it is not, would not matter. At this point, the efficacy of responding will do the talking for all. As he said 'the works on EFTI is looking for the standard of care, the better possible of treatment in line'

With the money part and the AIPAC ph3, I do feel that he is kinda confident about the financial support through a partnership. More likely we should see a paid-deal with AIPAC ph3 partnership.

With all these daily small volume pissing trade, especially with around 15-20% of short-sell volume everyday, I am feeling more asured about something is on the way. The daily price action is very precisely engineered.